Interactive associations of drug-drug and drug-drug-drug with iia subdomain of human serum albumin

Molecular Pharmaceutics

Volumn 9, Issue 11, 2012, Pages 3259-3265

  Yang, Feng ^a   Yue, Jiping ^b   Ma, Li ^a   Ma, Zhiyuan ^a   Li, Mei ^a   Wu, Xiaoyang ^b   Liang, Hong ^a  

^a GUANGXI NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

drug delivery systems; fluorescence spectroscopy; human serum albumin; protein?ligand interaction; X ray crystallography

Indexed keywords

ALANINE; ARGININE; CINNAMIC ACID; FATTY ACID; GLUTAMIC ACID; HISTIDINE; HUMAN SERUM ALBUMIN; INDOMETACIN; ISOLEUCINE; LAMIVUDINE; LEUCINE; PHENYLALANINE; SERINE; TRYPTOPHAN;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG PROTEIN BINDING; DRUG STRUCTURE; FLUORESCENCE SPECTROSCOPY; HYDROGEN BOND; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN DOMAIN; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CINNAMATES; CRYSTALLOGRAPHY, X-RAY; FATTY ACIDS; HUMANS; INDOMETHACIN; LAMIVUDINE; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE;

EID: 84868561047     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300322y     Document Type: Article

References (33)

1. Peters, T. All about albumin: biochemistry, genetics and medical applications; Academic Press: San Diego, 1995.
2. Colmenarejo, G. In silico prediction of drug-binding strengths to human serum albumin Med. Res. Rev. 2003, 3, 275-301
3. Fasano, M.; Curry, S.; Terreno, E.; Galliano, M.; Fanali, G.; Narciso, P.; Notari, S.; Ascenzi, P. The extraordinary ligand binding properties of human serum albumin IUBMB Life 2005, 57, 787-96
4. Elsadek, B.; Kratz, F. Impact of albumin on drug delivery - New applications on the horizon J. Controlled Release 2012, 157, 4-28
5. Kratz, F.; Elsadek, B. Clinical impact of serum proteins on drug delivery J. Controlled Release 2012, 161 (2) 429-445
6. Kratz, F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles J. Controlled Release 2008, 132, 171-183
7. Chatterjee, T.; Pal, A.; Dey, S.; Chatterjee, B. K.; Chakrabarti, P. Interaction of virstatin with human serum albumin: spectroscopic analysis and molecular modeling PLoS One 2012, 7, e37468
8. Hummer, A. A.; Bartel, C.; Arion, V. B.; Jakupec, M. A.; Meyer-Klaucke, W.; Geraki, T.; Quinn, P. D.; Mijovilovich, A.; Keppler, B. K.; Rompel, A. X-ray Absorption Spectroscopy of an Investigational Anticancer Gallium(III) Drug: Interaction with Serum Proteins, Elemental Distribution Pattern, and Coordination of the Compound in Tissue J. Med. Chem. 2012, 55 (11) 5601-5613
9. Oltersdorf, T.; Elmore, S. W.; Shoemaker, A. R.; Armstrong, R. C.; Augeri, D. J.; Rosenberg, S. H. An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 2005, 435, 677-681
10. Mao, H.; Fesik, S. W. Rational design of diflunisal analogues with reduced affinity for human serum albumin J. Am. Chem. Soc. 2001, 123, 10429-10435
11. He, X. M.; Carter, D. C. Atomic structure and chemistry of human serum albumin Nature 1992, 358, 209-215
12. Ghuman, J.; Zunszain, P. A.; Petitpas, I.; Bhattacharya, A. A.; Otagiri, M.; Curry, S. Structural basis of the drug-binding specificity of human serum albumin J. Mol. Biol. 2005, 353, 38-52
13. Guo, S.; Shi, X.; Yang, F.; Huang, M. Structural basis of transport of lysophospholipids by human serum albumin Biochem. J. 2009, 423, 23-30
14. Zunszain, P. A.; Ghuman, J.; McDonagh, A. F.; Curry, S. Crystallographic analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXalpha J. Mol. Biol. 2008, 381, 394-406
15. Junk, M. J.; Spiess, H. W.; Hinderberger, D. The distribution of fatty acids reveals the functional structure of human serum albumin Angew. Chem., Int. Ed. 2010, 49, 8755-8759
16. Blindauer, C. A.; Sadler, P. J. Structure, properties, and engineering of the major zinc binding site on human albumin J. Biol. Chem. 2009, 284, 23116-23124
17. Varshney, A.; Sen, P.; Ahmad, E.; Rehan, M.; Subbarao, N.; Khan, R. H. Ligand binding strategies of human serum albumin: How can the cargo be utilized? Chirality 2010, 22, 77-87
18. Fanali, G.; di Masi, A.; Trezza, V.; Marino, M.; Fasano, M.; Ascenzi, P. Human serum albumin: from bench to bedside Mol. Aspects Med. 2012, 33, 209-290
19. Ryan, A. J.; Curry, S. Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin J. Struct. Biol. 2011, 174, 84-91
20. Hein, K. L.; Kragh-Hansen, U.; Morth, J. P.; Jeppesen, M. D.; Otzen, D.; Müller, J. V.; Nissen, P. Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin J. Struct. Biol. 2011, 171, 353-360
21. Yamaguchi, S.; Uchida, K. Delta12-prostaglandin J2 as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146 J. Am. Chem. Soc. 2010, 132, 824-832
22. Petitpas, I.; Bhagavan, N. V. Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 6440-6445
23. Patra, D.; Barakat, C.; Tafech, R. M. Study on effect of lipophilic curcumin on sub-domain IIA site of human serum albumin during unfolded and refolded states: a synchronous fluorescence spectroscopic study Colloids Surf., B 2012, 94, 354-361
24. Abou-Zied, O. K.; AlShihi, O. I. Characterization of subdomain IIA binding site of human serum albumin in its native, unfolded, and refolded states using small molecular probes J. Am. Chem. Soc. 2008, 130, 10793-10801
25. Lakowicz, J. R. Principles of Fluorescence Spectroscopy; Kluwer Academic, Plenum Publishers: New York, 1999.
26. Eftink, M. R. Fluorescence Quenching: Theory and Applications Top. Fluoresc. Spectrosc. 2002, 2, 53-126
27. Ware, W. R. Oxygen quenching of fluorescence in solution: an experimental study of the diffusion process J. Phys. Chem. 1962, 66, 455-458
28. Gokara, M.; Sudhamalla, B.; Amooru, D. G.; Subramanyam, R. Molecular interaction studies of trimethoxy flavone with human serum albumin PLoS One 2010, 5, e8834
29. Zsila, F.; Bikádi, Z.; Simonyi, M. Probing the binding of the flavonoid, quercetin to human serum albumin by circular dichroism, electronic absorption spectroscopy and molecular modelling methods Biochem. Pharmacol. 2003, 65, 447-456
30. Curry, S.; Mandelkow, H.; Brick, P.; Franks, N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites Nat. Struct. Biol. 1998, 5, 827-835
31. DeLano, W. L. The PyMol Molecular Graphics System; DeLano Scientific: San Carlos, CA, 2004.
32. Sulkowska, A. Interaction of drugs with bovine and human serum albumin J. Mol. Struct. 2002, 614, 227-232
33. Bhattacharya, A. A.; Grune, T.; Curry, S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin J. Mol. Biol. 2000, 303, 721-732